Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Red Fox Peptides serves the Canadian research community with pharmaceutical-grade peptides including both Semaglutide and Semax
There is currently no specific contraindication to using GLP-1 receptor agonists in people with Crohn's disease, but this decision requires careful individualised assessment
The conclusion at this stage is that an alternative to the current oral and IV options may be found in the acetyletaed form of glutathione, and if further analysis and clinical experiences continue to support this as a valid clinical strategy, there will be many patients very pleased to have access to such a simple strategy to enhance GSH levels where required
Practical takeaway (late 2025): If youre using a GLP-1 for diabetes, Medi-Cal coverage can still apply (PA and diagnosis rules may apply)
